BSE Live
Apr 20, 16:01Prev. Close
71.72
Open Price
73.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 29, 15:53Prev. Close
84.05
Open Price
84.50
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
84.05 (809)
| Profit & Loss account of GKB Ophthalmics (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 32.75 | 31.18 | 27.68 | 26.86 | 20.90 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 32.75 | 31.18 | 27.68 | 26.86 | 20.90 | |
| Total Operating Revenues | 32.75 | 31.18 | 27.73 | 27.05 | 21.34 | |
| Other Income | 1.97 | 2.08 | 2.09 | 1.96 | 3.34 | |
| Total Revenue | 34.72 | 33.26 | 29.82 | 29.01 | 24.68 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 18.90 | 16.40 | 13.60 | 13.13 | 10.89 | |
| Purchase Of Stock-In Trade | 0.07 | 0.06 | 0.00 | 0.01 | 0.20 | |
| Operating And Direct Expenses | 0.00 | 1.07 | 0.00 | 1.39 | 0.00 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -0.50 | 0.26 | 0.07 | 0.60 | -1.16 | |
| Employee Benefit Expenses | 10.88 | 9.22 | 7.45 | 6.92 | 5.81 | |
| Finance Costs | 1.89 | 1.59 | 1.50 | 1.34 | 1.34 | |
| Depreciation And Amortisation Expenses | 2.64 | 2.59 | 2.54 | 2.49 | 2.99 | |
| Other Expenses | 6.88 | 5.45 | 7.70 | 5.44 | 6.19 | |
| Total Expenses | 40.76 | 36.63 | 32.86 | 31.32 | 26.25 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | -6.04 | -3.38 | -3.04 | -2.31 | -1.57 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | -0.72 | |
| Profit/Loss Before Tax | -6.04 | -3.38 | -3.04 | -2.31 | -2.29 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | 0.07 | 0.04 | -0.16 | 0.00 | -0.18 | |
| Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 0.07 | 0.04 | -0.16 | 0.00 | -0.18 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | -6.11 | -3.42 | -2.88 | -2.31 | -2.11 | |
| Profit/Loss From Continuing Operations | -6.11 | -3.42 | -2.88 | -2.31 | -2.11 | |
| Profit/Loss For The Period | -6.11 | -3.42 | -2.88 | -2.31 | -2.11 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | -12.12 | -6.78 | -5.72 | -4.58 | -4.18 | |
| Diluted EPS (Rs.) | -12.12 | -6.78 | -5.72 | -4.58 | -4.18 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Equity Dividend Rate (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
26.11.2025
GKB Ophthalmics Consolidated September 2025 Net Sales at Rs 30.17 crore, up 15.41% Y-o-Y
21.11.2025
GKB Ophthalmics Standalone September 2025 Net Sales at Rs 6.11 crore, down 26.05% Y-o-Y
06.06.2025
GKB Ophthalmics Standalone March 2025 Net Sales at Rs 8.43 crore, up 14.54% Y-o-Y
03.06.2025
GKB Ophthalmics Consolidated March 2025 Net Sales at Rs 31.02 crore, up 43.91% Y-o-Y
26.11.2025
GKB Ophthalmics Consolidated September 2025 Net Sales at Rs 30.17 crore, up 15.41% Y-o-Y
21.11.2025
GKB Ophthalmics Standalone September 2025 Net Sales at Rs 6.11 crore, down 26.05% Y-o-Y
06.06.2025
GKB Ophthalmics Standalone March 2025 Net Sales at Rs 8.43 crore, up 14.54% Y-o-Y
03.06.2025
GKB Ophthalmics Consolidated March 2025 Net Sales at Rs 31.02 crore, up 43.91% Y-o-Y
12.06.2024
05.06.2024
04.06.2024
04.06.2024
Rural recovery keeps consumer companies bullish on volume growth, but HUL differs: Jefferies
15.05.2024
Colgate aims to push for growth while sustaining margins, says CFO
14.05.2024
Colgate-Palmolive Q4 results: Net profit rises 20% to Rs 380 crore
06.05.2024
Marico commits Rs 70-100 crore to increase direct distribution reach over next 3 years
06.05.2024
Godrej Consumer posts consolidated net loss of Rs 1,893 crore in Q4; declares Rs 10 dividend
23.04.2024
Hindustan Unilever Q4 Preview: Price cuts, slow demand, regional competition to hurt topline
17.01.2024
HUL Q3 preview: Price cuts may hit topline, weak festive demand to limit volumes
17.10.2023
Hindustan Unilever Q2 PAT seen up 5.1% YoY to Rs 2,500 cr: Nirmal Bang
17.10.2023
Dabur India Q2 PAT seen up 2.1% YoY to Rs 500.4 cr: Nirmal Bang
25.04.2024
HUL in Q4: Revenue buoyed by premiumisation, rural recovery hinges on monsoon
26.02.2024
A for artificial intelligence, B for base effect: The A-Z of Q3 earnings season
13.02.2024
Q3 earnings: Cyclicals drive show amid margin boost; consumer staples in hot water
08.02.2024
Analyst call tracker: HUL, Asian Paints among struggling giants in consumption space